Β -THALASSEMIA
Clinical trials for Β -THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new Β -THALASSEMIA trials appear
Sign up with your email to follow new studies for Β -THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for thalassemia patients: drug trial targets anemia without transfusions
Disease control Not yet recruitingThis study tests a new drug called SNH-119014 in 30 adults with a type of thalassemia that does not need regular blood transfusions. The goal is to see if the drug is safe and helps improve anemia. Participants will be monitored for side effects and changes in their blood counts.
Matched conditions: Β -THALASSEMIA
Phase: PHASE2 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Greek study to measure daily life impact of iron overload drug
Knowledge-focused Not yet recruitingThis study looks at how thalassemia patients in Greece feel about their daily lives while taking a drug called deferasirox for iron overload from blood transfusions. Researchers will use a questionnaire to measure quality of life. The goal is to understand the real-world experien…
Matched conditions: Β -THALASSEMIA
Sponsor: Elpen Pharmaceutical Co. Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC